SPOTLIGHT -
FDA issues complete response letter to Aldeyra Therapeutics for reproxalap NDA
Thyroid eye disease: The masquerading eye disorder— a guide to accurate diagnosis and collaborative care
Eye care providers express concern over Q3 revenue, staffing, and inflation
Advances in treatment for geographic atrophy
Managing cases of dry eye: Expect the unexpected
This week in optometry: November 20-November 24